Pancreatic Cancer Trial, Recruiting NCT06944587 Sponsor: Oslo University Hospital Condition: Pancreatic Cancer
Back to Pancreatic Cancer

Pancreatic Cancer Trial, Recruiting

NCT06944587
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People diagnosed with pancreatic cancer (a specific type called adenocarcinoma) that is either "borderline resectable" (on the edge of being removable by surgery) or "locally advanced" (has grown beyond the pancreas but has not spread to distant parts of the body)
  • People whose cancer has not spread to distant organs (no distant metastases), based on standard cancer staging guidelines
  • People whose pancreatic cancer has been confirmed by a tissue or cell sample taken from the tumour
  • People aged over 18 years
  • People considered healthy enough to receive chemotherapy as the first treatment, and possibly surgery afterwards
  • People who are willing and able to provide written consent to participate in the trial

Who may not be able to join:

  • People whose other health conditions or overall health status mean chemotherapy would not be safe for them
  • People whose other health conditions or overall health status mean pancreatic surgery would not be safe for them
  • Women of childbearing age who are not using adequate contraception, or women who are pregnant or breastfeeding
  • People with mental or physical conditions that could interfere with their treatment or with their ability to give informed consent
  • People whom the trial investigator believes should not participate, for any reason

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +4723070000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
3 December 2024
Est. completion
31 December 2028

Where this trial is recruiting

🇳🇴 Norway

Primary endpoints

Resection rate (of the pancreatic tumour)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov